Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data

被引：15
作者：
Sharma, Ashish [1 ]
Hafeez Faridi, M. [2 ]
Kumar, Nilesh [1 ]
Parachuri, Nikulaa [1 ]
Sharma, Rohini [3 ]
Kuppermann, Baruch D. [4 ]
Bandello, Francesco [5 ]
Loewenstein, Anat [6 ,7 ]
Regillo, Carl D. [8 ]
机构：
[1] Lotus Eye Hosp & Inst, Dept Vitreoretina, Coimbatore, TN, India
[2] Chicago State Univ, Coll Pharm, Chicago, IL USA
[3] TIPS Global Inst, Dept Healthcare, Coimbatore, Tamil Nadu, India
[4] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA USA
[5] Univ Vita Salute, Dept Ophthalmol, Sci Inst San Raffaele, Milan, Italy
[6] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Ophthalmol, Tel Aviv, Israel
[7] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[8] Wills Eye Hosp & Res Inst, Mid Atlantic Retina, Retina Serv, Philadelphia, PA USA
来源：
EYE | 2020年 / 34卷 / 06期
关键词：
D O I：
10.1038/s41433-019-0745-z
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1008 / 1009
页数：2
相关论文
共 7 条
  • [1] Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
    Jorgensen, Kristin K.
    Olsen, Inge C.
    Goll, Guro L.
    Lorentzen, Merete
    Bolstad, Nils
    Haavardsholm, Espen A.
    Lundin, Knut E. A.
    Mork, Cato
    Jahnsen, Jorgen
    Kvien, Tore K.
    [J]. LANCET, 2017, 389 (10086) : 2304 - 2316
  • [2] Switching from infliximab to biosimilar in inflammatory bowel disease: overview of the literature and perspective
    Milassin, Agnes
    Fabian, Anna
    Molnar, Tames
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [3] Ophthalmic biosimilars: Lessons from India
    Sharma, Ashish
    Kumar, Nilesh
    Kuppermann, Baruch D.
    Francesco, Bandello
    Lowenstein, Anat
    [J]. INDIAN JOURNAL OF OPHTHALMOLOGY, 2019, 67 (08) : 1384 - +
  • [4] Biotherapeutics and immunogenicity: ophthalmic perspective
    Sharma, Ashish
    Kumar, Nilesh
    Kuppermann, Baruch D.
    Francesco, Bandello
    Loewenstein, Anat
    [J]. EYE, 2019, 33 (09) : 1359 - 1361
  • [5] Biosimilars in ophthalmology: "Is there a big change on the horizon?"
    Sharma, Ashish
    Reddy, Prahalad
    Kuppermann, Baruch D.
    Bandello, Francesco
    Lowenstein, Anat
    [J]. CLINICAL OPHTHALMOLOGY, 2018, 12 : 2137 - 2143
  • [6] Real-Life Clinical Effectiveness of Razumab® (the World's First Biosimilar of Ranibizumab) in Retinal Vein Occlusion: A Subgroup Analysis of the Pooled Retrospective RE-ENACT Study
    Sharma, Shashikant
    Khan, Mujtaba A.
    Chaturvedi, Alok
    [J]. OPHTHALMOLOGICA, 2019, 241 (01) : 24 - 31
  • [7] Lacrimal drainage anomalies in Tessier cleft 3 with unilateral anophthalmos
    Singh, Swati
    Sharma, Abhimanyu
    Mittal, Vikas
    Ali, Mohammad Javed
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (02) : NP12 - NP14
1